- Nachrichtendetail
-
24.06.2024 13:57:55 - dpa-AFX: *BIOGEN'S TOFIDENCE BIOSIMILAR RECEIVES EC APPROVAL FOR MULTIPLE INDICATIONS INCL. COVID-19 TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Biogen | 789617 | NASDAQ | 204,620 | 23.08.24 20:40:27 | +1,300 | +0,64% | 204,560 | 204,750 | 204,500 | 203,320 |
